Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5,169,697
-
Total 13F shares
-
1,867,063
-
Share change
-
+351,890
-
Total reported value
-
$557,115
-
Price per share
-
$0.30
-
Number of holders
-
14
-
Value change
-
+$77,507
-
Number of buys
-
9
-
Number of sells
-
2
Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q2 2024
As of 30 Jun 2024 CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,867,063 shares of stock of the company.
Largest 10 holders included ARCH Venture Management, LLC, Arena Investors LP, Avantax Planning Partners, Inc., GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, TWO SIGMA INVESTMENTS, LP, Corient Private Wealth LLC, Birchview Capital, LP, HRT FINANCIAL LP, and FNY Investment Advisers, LLC.
This table shows 14 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.